The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

Alan Fauconnier; Tobi E. Nagel; Charlotte Fauconnier; Gilbert Verbeken; Daniel De Vos; Maia Merabishvili; Jean Paul Pirnay

doi:10.3389/fmicb.2020.01982

The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

Alan Fauconnier, Tobi E. Nagel, Charlotte Fauconnier, Gilbert Verbeken, Daniel De Vos, Maia Merabishvili, Jean Paul Pirnay

Laboratory for Molecular and Cellular Technology

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

langue originale	Anglais
Numéro d'article	1982
journal	Frontiers in Microbiology
Volume	11
Les DOIs	https://doi.org/10.3389/fmicb.2020.01982
état	Publié - 3 sept. 2020

Accès au document

10.3389/fmicb.2020.01982

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{c50381ac37f94c3aac54b2bdb3ad87f4,

title = "The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis",

keywords = "GMP, World Health Organization, database, deep learning, local production, low and middle-income countries, phage therapy, regulatory framework",

author = "Alan Fauconnier and Nagel, {Tobi E.} and Charlotte Fauconnier and Gilbert Verbeken and {De Vos}, Daniel and Maia Merabishvili and Pirnay, {Jean Paul}",

year = "2020",

month = sep,

day = "3",

doi = "10.3389/fmicb.2020.01982",

language = "English",

volume = "11",

journal = "Frontiers in Microbiology",

issn = "1664-302X",

}

TY - JOUR

T1 - The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

AU - Fauconnier, Alan

AU - Nagel, Tobi E.

AU - Fauconnier, Charlotte

AU - Verbeken, Gilbert

AU - De Vos, Daniel

AU - Merabishvili, Maia

AU - Pirnay, Jean Paul

PY - 2020/9/3

Y1 - 2020/9/3

KW - GMP

KW - World Health Organization

KW - database

KW - deep learning

KW - local production

KW - low and middle-income countries

KW - phage therapy

KW - regulatory framework

UR - http://www.scopus.com/inward/record.url?scp=85091284661&partnerID=8YFLogxK

U2 - 10.3389/fmicb.2020.01982

DO - 10.3389/fmicb.2020.01982

M3 - Article

AN - SCOPUS:85091284661

SN - 1664-302X

VL - 11

JO - Frontiers in Microbiology

JF - Frontiers in Microbiology

M1 - 1982

ER -